Quantinno Capital Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,081
Closed -$511K 844
2022
Q3
$511K Buy
2,081
+112
+6% +$30.2K 0.07% 361
2022
Q2
$487K Buy
+1,969
New +$531K 0.07% 344
2022
Q1
Sell
-697
Closed -$250K 593
2021
Q4
$250K Buy
+697
New +$235K 0.05% 446
2019
Q3
Sell
-1,073
Closed -$280K 549
2019
Q2
$280K Buy
1,073
+191
+22% +$50.7K 0.16% 307
2019
Q1
$252K Buy
+882
New +$293K 0.16% 302

Other funds holding ABMD

Quantinno Capital Management's ABMD Position: Q4 2022 in Review

Quantinno Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,081 shares — an estimated $511K sold.

Quantinno Capital Management first reported a position in ABMD in Q1 2019 and held it in 5 quarters. The position peaked at $511K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Quantinno Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Quantinno Capital Management sold 2,081 Abiomed Inc shares in Q4 2022, an estimated $511K.
  • Quantinno Capital Management first reported a position in Abiomed Inc in Q1 2019 and held it in 5 quarters.
  • Quantinno Capital Management's Abiomed Inc position peaked at $511K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Quantinno Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.